Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-13 Purchase | 2024-02-21 5:00 pm | NewAmsterdam Pharma Co N.V. | NAMS | LANGE LOUIS G Director | 5,000 | $19 | $95,000 | 24,878 (Indirect) | View |
| 2019-12-23 Sale | 2019-12-27 4:10 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 11,000 | $59.6 | $655,589 | 315,375 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2024-01-25 5:00 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | LANGE LOUIS G Director | 0 | $0 | 234,683 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:17 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | LANGE LOUIS G Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | LANGE LOUIS G Director | 0 | $0 | 237,647 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 315,375 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 53,200 | $0 | 0 (Direct) | View |